Survival benefit of pancreatic metastasectomy of clear cell renal cell carcinoma  

作　　者：Yuan Fang Min Tang Wen-Tao Zhou Wen-Hui Lou 

机构地区：[1]Department of Pancreatic Surgery,Zhongshan Hospital,Fudan University,Shanghai 200032,China [2]Department of Radiology,Zhongshan Hospital,Fudan University,Shanghai 200032,China

出　　处：《Chinese Medical Journal》2019年第22期2751-2753,共3页中华医学杂志（英文版）

基　　金：a grant from the National Natural Science Foundation of China(No.81702964).

摘　　要：The clear cell renal cell carcinoma(ccRCC)appears to have a predilection for metastasizing to the pancreas/11 In the recent years,there are increasing numbers of clinical series from Europe and the United States that demonstrate encouraging survival results of pancreatic metastasectomy,121 but there are a few clinical data or only some case reports from East Asian population,[3] and there are no specific guidelines regarding the appropriate management.The objective of this study was to present our experience of pancreatic metastasectomy from ccRCC by reporting the peri-operative and survival outcome.

关 键 词：SURVIVAL CLINICAL OPERATIVE 

分 类 号：R73[医药卫生—肿瘤]